Vanderbilt investigators used an in vivo screen in zebrafish to identify a potential new anti-cancer drug.

New mass spectrometry imaging methods will enable studies of the distribution and identification of membrane proteins directly within tissues.

Therapeutic nanoparticles may offer a powerful new way to image and treat cancer at the same time.

Vanderbilt investigators have combined next-generation sequencing technologies and bioinformatics analyses to screen for genome-wide genetic mutations associated with drug resistance in a series of lung cancer cell lines.

Wylie Burke, M.D., Ph.D., an expert in the social, ethical and policy implications of genetic information, will deliver the next Flexner Discovery Lecture on Thursday, Sept. 19.

A coronavirus protein is required for replication of the viral genome and may be a good treatment target for SARS and other diseases caused by coronaviruses.